Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen T. Worland currently holds 12,494 shares of ANADYS PHARMACEUTICALS INC (ANDS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen T. Worland has been a net buyer of ANDS stock. They have purchased $333.3K and sold $148.0K worth of shares.
Stephen T. Worland's most recent insider trade was on May 15, 2024, when they sold 1,806 shares at $1.68 per share.
Stephen T. Worland serves as Executive at ANADYS PHARMACEUTICALS INC (ANDS). They have executed 30 insider transactions totaling $481.3K over their tenure at the company.
Stephen T. Worland holds the position of Executive at ANADYS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Stephen T. Worland has shown a buying trading pattern, with $333.3K in total purchases and $148.0K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Stephen T. Worland was on Aug 25, 2021, when they purchased $500.0K worth of EFTR shares. This transaction involved 50,000 shares at $10.00 per share.
Stephen T. Worland currently owns 12,494 shares of ANADYS PHARMACEUTICALS INC (ANDS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen T. Worland's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen T. Worland has 30 Form 4 filings on record as an insider at ANADYS PHARMACEUTICALS INC.
Set alerts for Stephen T. Worland and 40,000+ other insiders.